Biennials of Sinop, Çanakkale, and Mardin in the context of biennalization
2021
0 views
0 downloads
Advisor: Prof. Dr. Gülden Demet Lüküslü
Abstract (EN)
Since 1987, Turkey became an important figure in the international art scene due to the organization of the Istanbul Biennale. Other cities like Sinop, Çanakkale, and Mardin also organized their own biennials, however, there is a lack of studies conducted concerning those biennials. This study aims to present a useful source of information about the biennials of Sinop, Çanakkale, and Mardin while discussing them in the larger context of biennalization. To accomplish this goal, a series of interviews were made with the founders and organizers of those biennials. In the light of these interviews, it is evident that the biennials of Sinop, Çanakkale, and Mardin form a more efficient relationship with their locality and they may be considered as qualitatively more successful examples when compared with the large-scale biennials like the Istanbul Biennale. Furthermore, this discussion also stresses the need for questioning the dichotomy between "central" and "peripheral" biennials while presenting the need for a new understanding.
Author
Begüm Güney
Institution
How to Cite
Begüm Güney (Master Thesis). Biennials of Sinop, Çanakkale, and Mardin in the context of biennalization, 2021, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)